A comparison of adriamycin and mAMSA in vitro: cell lethality and SCE studies.

Br J Cancer · 1981 · PMC2010861 · PMID 6895696

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may not be significantno p-value reported

This change in the form of the distribution may result from slight variation in cycle-stage sensitivity to drug action, and therefore the difference between ADM and mAMSA at this dose level may not be significant.

also in 2,774 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.